Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 2/3 1Phase 2 1

Status

Completed 6Terminated 2Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6

Conditions

Breast Neoplasms 1484Neoplasms 1101Carcinoma, Non-Small-Cell Lung 918Prostatic Neoplasms 802Multiple Myeloma 586Colorectal Neoplasms 535Leukemia, Myeloid, Acute 505Lung Neoplasms 489Lymphoma 455Melanoma 454Neoplasm Metastasis 451Lymphoma, Non-Hodgkin 416Leukemia 409Leukemia, Lymphocytic, Chronic, B-Cell 366Ovarian Neoplasms 357Pancreatic Neoplasms 338Precursor Cell Lymphoblastic Leukemia-Lymphoma 334Recurrence 315Head and Neck Neoplasms 298Lymphoma, Follicular 297Myelodysplastic Syndromes 282Carcinoma, Renal Cell 272Glioblastoma 266Brain Neoplasms 265Hodgkin Disease 260Lymphoma, Large B-Cell, Diffuse 255Carcinoma, Hepatocellular 241Lymphoma, Mantle-Cell 219Squamous Cell Carcinoma of Head and Neck 214Stomach Neoplasms 210

Interventions

niraparib 1Watchful Waiting 1Receptors, Bombesin 1Radiotherapy 1Radiation Dose Hypofractionation 1Radiation 1Observation 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Gallium 1Cholecalciferol 1BAY 86-7548 1Adjuvants, Pharmaceutic 168Ga-bombesin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Has results × Prostate Adenocarcinoma × Clear all
NCT03274687 2026-05-20

Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

NRG Oncology

Phase 3 Completed
296 enrolled 29 charts
Genitourinary

Prostate Adenocarcinoma

NCT04288687 2026-03-04

A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects

Abramson Cancer Center at Penn Medicine

Phase 2 Completed
11 enrolled 13 charts
Genitourinary

Prostate Adenocarcinoma

NCT03860961 2025-11-03

Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy

NRG Oncology

Phase NA Completed
550 enrolled 13 charts
Genitourinary

Prostate Adenocarcinoma

NCT02624518 2023-04-10

68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer

Stanford University

Phase 2/3 Completed
122 enrolled 8 charts
Genitourinary

Prostate Adenocarcinoma

NCT00887432 2021-10-26

Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation

Roswell Park Cancer Institute

Phase NA Completed
132 enrolled 11 charts
Genitourinary

Prostate Adenocarcinoma

NCT02175212 2020-11-20

AADLPC

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Phase 3 Completed
362 enrolled 17 charts
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡